News

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), GE Aerospace ...
Trulicity’s performance was a big positive for Lilly however, as there had been speculation that it might start to slow down thanks to the challenge from Ozempic – which has outperformed it in ...
New phase 3b trial results show Lilly’s Trulicity has helped type 2 diabetes patients already taking an SGLT2 inhibitor but whose blood sugar was inadequately controlled. The AWARD trial showed ...
Lilly’s new products also contributed to sales growth. Trulicity sales continued to decline in the quarter. Lilly maintained its sales guidance for 2025 while lowering its earnings expectations ...
Eli Lilly and Company’s LLY shares have lost 17% so far in May. Lilly announced mixed earnings results on May 1. It missed first-quarter estimates for earnings but beat the same for sales. Sales of ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...
Lilly built a pilot mini-foundry 20 years ago, and the diabetes drug Trulicity blossomed out of research there, along with a new breakthrough medicine to treat Alzheimer’s disease and others ...
Zacks highlights LLY, GE, and AMGN as top picks, citing strong demand, product pipelines, and defense tailwinds despite some ...